These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28659986)

  • 41. Impact of obsessive-compulsive disorder on quality of life.
    Eisen JL; Mancebo MA; Pinto A; Coles ME; Pagano ME; Stout R; Rasmussen SA
    Compr Psychiatry; 2006; 47(4):270-5. PubMed ID: 16769301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.
    Grant JE; Kim SW; Odlaug BL
    Biol Psychiatry; 2007 Sep; 62(6):652-7. PubMed ID: 17445781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deep brain stimulation versus anterior capsulotomy for obsessive-compulsive disorder: a review of the literature.
    Pepper J; Hariz M; Zrinzo L
    J Neurosurg; 2015 May; 122(5):1028-37. PubMed ID: 25635480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapist-Guided, Internet-Delivered Cognitive-Behavioral Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Trial.
    Lenhard F; Andersson E; Mataix-Cols D; Rück C; Vigerland S; Högström J; Hillborg M; Brander G; Ljungström M; Ljótsson B; Serlachius E
    J Am Acad Child Adolesc Psychiatry; 2017 Jan; 56(1):10-19.e2. PubMed ID: 27993223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Efficacy of fluvoxamine combined with extended-release methylphenidate on treatment-refractory obsessive-compulsive disorder].
    Zheng H; Jia F; Guo G; Quan D; Li G; Huang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 43(11):1230-1235. PubMed ID: 30643068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Orgasm, Serotonin Reuptake Inhibition, and Plasma Oxytocin in Obsessive-Compulsive Disorder. Gleaning From a Distant Randomized Clinical Trial.
    Humble MB; Bejerot S
    Sex Med; 2016 Sep; 4(3):e145-55. PubMed ID: 27320409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial of adjunctive N-Acetylcysteine for treatment-resistant PTSD.
    Kanaan RA; Oliver G; Dharan A; Sendi S; Maier A; Mohebbi M; Ng C; Back SE; Kalivas P; Berk M
    Psychiatry Res; 2023 Sep; 327():115398. PubMed ID: 37540942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized controlled trial of adjunctive EEG-biofeedback treatment of obsessive-compulsive disorder.
    Deng X; Wang G; Zhou L; Zhang X; Yang M; Han G; Tu Z; Liu B
    Shanghai Arch Psychiatry; 2014 Oct; 26(5):272-9. PubMed ID: 25477720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Effect of Atorvastatin on Obsessive-compulsive Symptoms of Refractory Obsessive-compulsive Disorder (Add-on Therapy).
    Akouchekian S; Omranifard V; Moshfegh P; Maracy MR; Almasi A
    Adv Biomed Res; 2018; 7():90. PubMed ID: 29930930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The therapeutic effect of N-acetylcysteine as an add-on to methadone maintenance therapy medication in outpatients with substance use disorders: A randomized, double-blind, placebo-controlled clinical trial.
    Padoei F; Mamsharifi P; Hazegh P; Boroumand H; Ostadmohammady F; Abbaszadeh-Mashkani S; Banafshe HR; Matini AH; Ghaderi A; Dehkohneh SG
    Brain Behav; 2023 Jan; 13(1):e2823. PubMed ID: 36448959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.
    Gray KM; Carpenter MJ; Baker NL; DeSantis SM; Kryway E; Hartwell KJ; McRae-Clark AL; Brady KT
    Am J Psychiatry; 2012 Aug; 169(8):805-12. PubMed ID: 22706327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review.
    Oliver G; Dean O; Camfield D; Blair-West S; Ng C; Berk M; Sarris J
    Clin Psychopharmacol Neurosci; 2015 Apr; 13(1):12-24. PubMed ID: 25912534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Could dietary glutamate be contributing to the symptoms of obsessive-compulsive disorder?
    Holton KF; Cotter EW
    Future Sci OA; 2018 Mar; 4(3):FSO277. PubMed ID: 29568566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of Oral Mucoadhesive N-Acetylcysteine Tablets in Treatment of Recurrent Aphthous Stomatitis: A Randomized Double-Blind, Placebo-Controlled Clinical Trial.
    Eslami G; Ghorbani A; Akbari J; Farmoudeh A; Faghih F; Moghimi M
    Front Dent; 2023; 20():18. PubMed ID: 37701655
    [No Abstract]   [Full Text] [Related]  

  • 55. N-acetylcysteine in the treatment of compulsive sexual behavior disorder: A case series.
    Blum AW; Grant JE
    J Psychiatr Res; 2022 Oct; 154():203-206. PubMed ID: 35952519
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Wasserthal S; Muthesius A; Hurlemann R; Ruhrmann S; Schmidt SJ; Hellmich M; Schultze-Lutter F; Klosterkötter J; Müller H; Meyer-Lindenberg A; Poeppl TB; Walter H; Hirjak D; Koutsouleris N; Fallgatter AJ; Bechdolf A; Brockhaus-Dumke A; Mulert C; Philipsen A; Kambeitz J
    Schizophr Bull Open; 2024 Jan; 5(1):sgae005. PubMed ID: 39144108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial.
    Carmi L; Tendler A; Bystritsky A; Hollander E; Blumberger DM; Daskalakis J; Ward H; Lapidus K; Goodman W; Casuto L; Feifel D; Barnea-Ygael N; Roth Y; Zangen A; Zohar J
    Focus (Am Psychiatr Publ); 2022 Jan; 20(1):152-159. PubMed ID: 35746941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks).
    Schwalfenberg GK
    J Nutr Metab; 2021; 2021():9949453. PubMed ID: 34221501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correction to: N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial.
    Alcohol Alcohol; 2024 Jan; 59(1):. PubMed ID: 38152918
    [No Abstract]   [Full Text] [Related]  

  • 60. Lack of efficacy of oral N-acetylcysteine ​​in the treatment of facial melasma in women: a randomized, double-blind, placebo-controlled clinical trial.
    Alfredo MAC; Holanda IRM; Cassiano DP; Espósito ACC; Lima PB; Miot HA
    An Bras Dermatol; 2024; 99(6):928-931. PubMed ID: 39112288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.